Anti-ERBB2/HER2/CD340 Antibody (Anbenitamab)
Catalog No.
F1434
Anti-ERBB2/HER2/CD340 Antibody (Anbenitamab)
Featured Products
Anbenitamab (KN-026) is a bispecific antibody that simultaneously targets the extracellular domains II and IV of human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathways. The IgG1 Fc fragment of Anbenitamab binds to FcRγIIIa to mediate potent antibody-dependent cell-mediated cytotoxicity (ADCC) and inhibit tumor cell proliferation. Anbenitamab has the potential to be used in the study of HER2-positive metastatic breast cancer (MBC).
145.16 kDa
Dry ice
2367012-88-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Herceptarg
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P04626
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ERBB2 / HER2 / CD340
Please avoid freeze-thaw cycles.